Logo image of QK

Q&K INTERNATIONAL GROUP-ADR (QK) Stock Fundamental Analysis

NASDAQ:QK - Nasdaq - US74738J2015 - ADR - Currency: USD

2.74  +0.03 (+1.11%)

Fundamental Rating

1

Taking everything into account, QK scores 1 out of 10 in our fundamental rating. QK was compared to 65 industry peers in the Real Estate Management & Development industry. Both the profitability and financial health of QK have multiple concerns. QK is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

QK had negative earnings in the past year.
QK Yearly Net Income VS EBIT VS OCF VS FCFQK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 0 -500M -1B -1.5B

1.2 Ratios

Industry RankSector Rank
ROA -150.72%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
QK Yearly ROA, ROE, ROICQK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 0 50 -50 -100 -150

1.3 Margins

Industry RankSector Rank
OM -16.4%
PM (TTM) -54.93%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
QK Yearly Profit, Operating, Gross MarginsQK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 0 -20 -40 -60 -80 -100

More info and screens

0

2. Health

2.1 Basic Checks

QK does not have a ROIC to compare to the WACC, probably because it is not profitable.
QK has more shares outstanding than it did 1 year ago.
The debt/assets ratio for QK is higher compared to a year ago.
QK Yearly Shares OutstandingQK Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 200M 400M 600M 800M
QK Yearly Total Debt VS Total AssetsQK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of -23.54, we must say that QK is in the distress zone and has some risk of bankruptcy.
QK has a Debt/Equity ratio of -0.21. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity -0.21
Debt/FCF N/A
Altman-Z -23.54
ROIC/WACCN/A
WACC5.7%
QK Yearly LT Debt VS Equity VS FCFQK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 0 -1B -2B

2.3 Liquidity

QK has a Current Ratio of 0.08. This is a bad value and indicates that QK is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.08 indicates that QK may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.08
Quick Ratio 0.08
QK Yearly Current Assets VS Current LiabilitesQK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 500M 1B 1.5B 2B

More info and screens

6

3. Growth

3.1 Past

QK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 66.20%, which is quite impressive.
QK shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -14.22%.
QK shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 18.66% yearly.
EPS 1Y (TTM)66.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.95%
Revenue 1Y (TTM)-14.22%
Revenue growth 3Y5.2%
Revenue growth 5Y18.66%
Sales Q2Q%-27.52%

3.2 Future

Based on estimates for the next years, QK will show a very strong growth in Earnings Per Share. The EPS will grow by 25.43% on average per year.
QK is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 54.10% yearly.
EPS Next Y98.3%
EPS Next 2Y40.48%
EPS Next 3Y25.43%
EPS Next 5YN/A
Revenue Next Year49.39%
Revenue Next 2Y52.34%
Revenue Next 3Y54.1%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
QK Yearly Revenue VS EstimatesQK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B
QK Yearly EPS VS EstimatesQK Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 -20 -40 -60

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for QK. In the last year negative earnings were reported.
Also next year QK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
QK Price Earnings VS Forward Price EarningsQK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -45.17
QK Per share dataQK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1 -1.5 -2

4.3 Compensation for Growth

A more expensive valuation may be justified as QK's earnings are expected to grow with 25.43% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.48%
EPS Next 3Y25.43%

More info and screens

0

5. Dividend

5.1 Amount

QK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Q&K INTERNATIONAL GROUP-ADR

NASDAQ:QK (9/23/2022, 8:23:17 PM)

2.74

+0.03 (+1.11%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)N/A N/A
Earnings (Next)10-11 2022-10-11/bmo
Inst Owners0.01%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap474.61M
Analysts40
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.26
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA -45.17
EPS(TTM)-0.5
EYN/A
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.84
BVpS-2.02
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -150.72%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -16.4%
PM (TTM) -54.93%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover2.74
Health
Industry RankSector Rank
Debt/Equity -0.21
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.08
Quick Ratio 0.08
Altman-Z -23.54
F-Score4
WACC5.7%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.95%
EPS Next Y98.3%
EPS Next 2Y40.48%
EPS Next 3Y25.43%
EPS Next 5YN/A
Revenue 1Y (TTM)-14.22%
Revenue growth 3Y5.2%
Revenue growth 5Y18.66%
Sales Q2Q%-27.52%
Revenue Next Year49.39%
Revenue Next 2Y52.34%
Revenue Next 3Y54.1%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A